MenC Immunisation Uptake Reports 2014 - 2018

MenC (meningococcal group C) vaccine is recommended as part of the primary childhood immunisation programme. In recent years, evidence has emerged that immunity to meningococcal disease reduces over time, so a booster dose is recommended now to provide additional protection. The MenC booster vaccine was introduced into the HSE schools immunisation programme in September 2014 following NIAC recommendation it be given to children aged 12-13 years of age. This vaccine was offered to students in first year of second level schools and their age equivalents in special schools and home schooled. In the 2019/2020 academic year the meningococcal ACWY (MenACWY) vaccine, which protects against meningococcal disease caused by Men C and also  types A, W and Y, was offered instead of MenC to this age group.